TCH-165 enhances 20S-mediated degradation of IDPs
Fifteen of 19 BCL6-positive cases (79%) display greater than 25% loss of viability in response to CID5721353 at 125 or 250 μM
extracted from patent WO 2008021331 A2
Ubenimex synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma
Tumulosic acid
Mogroside IIA1 Size:Contact [email protected] for quotation TCH-165 enhances 20S-mediated degradation ofMogroside IIA1 is a triterpenoid glycoside and a nonsugar sweetener. Mogrosides are sweeter than sucrose. Mogrosides exhibit antioxidant, antidiabetic and anticancer activities. Product information CAS Number: 88901 44 4 Molecular Weight: 801. 01 Formula: C42H72O14 Chemical Name: 2 [(6 {7,10 dihydroxy 3a,6,6,9b,11a pentamethyl 1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH cyclopenta[a]phenanthren 1 yl} 2 hydroxy 2 methylheptan 3 yl)oxy] 6